Nuclear FoxO1 acts as a transcriptional repressor to downregulate JAK1/JAK2 expression, leading to reduced STAT3 phosphorylation at Tyr705, as demonstrated by Western blot and immunohistochemistry, which effectively disrupts a key survival pathway in hypoxic tumor cells [87]. The gene discussed is FOXO1; the disease is neoplasm.